1,201
Views
6
CrossRef citations to date
0
Altmetric
Research Paper

Potent carbonic anhydrase I, II, IX and XII inhibition activity of novel primary benzenesulfonamides incorporating bis-ureido moieties

, , , , & ORCID Icon
Article: 2185762 | Received 30 Jan 2023, Accepted 22 Feb 2023, Published online: 02 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Claudiu T Supuran. (2023) Targeting carbonic anhydrases for the management of hypoxic metastatic tumors. Expert Opinion on Therapeutic Patents 33:11, pages 701-720.
Read now

Articles from other publishers (5)

Vikas Sharma, Lalit Vats, Simone Giovannuzzi, Brij Mohan, Claudiu T. Supuran & Pawan K. Sharma. (2024) In‐vitro and in‐silico investigations of SLC‐0111 hydrazinyl analogs as human carbonic anhydrase I, II, IX, and XII inhibitors. Archiv der Pharmazie.
Crossref
Samer Tareq Jasim & Monther F. Mahdi. (2024) Molecular Modeling, Synthesis, and preliminary pharmacological evaluation of New Sulfonamide Derivatives as Selective Carbonic Anhydrase XII and IX inhibitors (Research). Al Mustansiriyah Journal of Pharmaceutical Sciences 24:2, pages 137-149.
Crossref
Minahil Hayat, Mehwish Sarfaraz, Muhammad Mohsin & Sayyad Ali Raza Bukhari. (2024) Carbonic anhydrase hybrid nanoflowers: From facile synthesis to their therapeutic prospects; the known, the unknown and the future. European Polymer Journal 210, pages 112930.
Crossref
Gönül Yapar, Nebih Lolak, Alessandro Bonardi, Suleyman Akocak & Claudiu T. Supuran. (2024) Exploring the potency of diazo‐coumarin containing hybrid molecules: Selective inhibition of tumor‐associated carbonic anhydrase isoforms IX and XII. ChemMedChem 19:4.
Crossref
Claudiu T. Supuran. (2023) A simple yet multifaceted 90 years old, evergreen enzyme: Carbonic anhydrase, its inhibition and activation. Bioorganic & Medicinal Chemistry Letters 93, pages 129411.
Crossref